324
Views
4
CrossRef citations to date
0
Altmetric
Review

Treating breast cancer with cell-based approaches: an overview

, , , &
Pages 1255-1264 | Received 14 Apr 2017, Accepted 14 Jul 2017, Published online: 20 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yanlin Song, Lu Li, Jiao Chen, Hongli Chen, Bomiao Cui, Yun Feng, Ping Zhang, Qiangsheng Zhang, Yong Xia & Min Luo. (2020) Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis. Cell Cycle 19:24, pages 3521-3533.
Read now
Roberta Sommaggio, Elisa Cappuzzello, Anna Dalla Pietà, Anna Tosi, Pierangela Palmerini, Debora Carpanese, Lorenzo Nicolè & Antonio Rosato. (2020) Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells. OncoImmunology 9:1.
Read now

Articles from other publishers (2)

Dahu Chen, Mei Yuan, Qin Ye, Xing Wang, Jing Xu, Guangyi Shi & Zhaodi Hu. (2020) Cyanidin-3-O-glucoside inhibits epithelial-to-mesenchymal transition, and migration and invasion of breast cancer cells by upregulating KLF4. Food & Nutrition Research 64:0.
Crossref
Eleonora Timperi, Elena Vissio, Caterina Marchiò & Emanuela Romano. 2020. Tumor Microenvironment. Tumor Microenvironment 215 249 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.